REQUEST A DEMO
Total
USD $0.00
Search more companies

Anglo Pharma S.A. (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Anglo Pharma S.A. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Anglo Pharma S.A. is an enterprise based in Colombia. Its main office is in Bogota D.C.. The company operates in the Pharmaceutical Preparation Manufacturing sector. The enterprise was incorporated on March 01, 1984. It currently has a total number of 105 (2024) employees. In its most recent financial highlights, the company reported a net sales revenue drop of 10.51% in 2023. Its’ total assets recorded a negative growth of 5.82%. The net profit margin of Anglo Pharma S.A. increased by 4.81% in 2023.

Headquarters
Cr 24 76 35
Bogota D.C.; Bogota D.C; Postal Code: 0816

Contact Details: Purchase the Anglo Pharma S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Anglo Pharma S.A. report to view the information.
Outstanding Shares:
Purchase the Anglo Pharma S.A. report to view the information.
Registered Capital:
Purchase the Anglo Pharma S.A. report to view the information.
Incorporation Date:
March 01, 1984
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Deputy Member of the Board of Directors
Purchase this report to view the information.
Deputy Member of the Board of Directors
Company Performance
Financial values in the chart are available after Anglo Pharma S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-10.51%
Total operating revenue
-8.97%
Operating profit (EBIT)
21.47%
EBITDA
19.38%
Net Profit (Loss) for the Period
58.74%
Total assets
-5.82%
Total equity
10.62%
Operating Profit Margin (ROS)
3.95%
Net Profit Margin
4.81%
Return on Equity (ROE)
2.91%
Debt to Equity Ratio
-10.04%
Quick Ratio
-0.04%
Cash Ratio
-0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?